Rakovina Therapeutics Inc.
RKVTF
$0.10
$0.00-4.61%
OTC PK
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -5.92M | -5.42M | -5.42M | -3.92M |
| Total Depreciation and Amortization | -- | 383.30K | 384.30K | 384.30K | 385.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 591.40K | 281.30K | 278.50K | 295.70K |
| Change in Net Operating Assets | -- | -116.40K | -579.00K | -579.00K | -222.00K |
| Cash from Operations | -- | -5.06M | -5.33M | -5.33M | -3.46M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 1.35M | 1.35M | 1.35M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 6.56M | 6.86M | 6.86M | 4.92M |
| Repurchase of Common Stock | -- | -16.70K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -263.60K | -289.70K | -289.70K | -188.40K |
| Cash from Financing | -- | 5.49M | 5.70M | 5.70M | 3.41M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 429.80K | 370.30K | 370.30K | -52.10K |